Detailed Information
Cited 28 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Dose-escalation and dose-expansion study of trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2+gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03
- Authors
- Janjigian, YY[Janjigian, Yelena Y.]; Oh, DY[Oh, Do-Youn]; Rha, SY[Rha, Sun Young]; Lee, KW[Lee, Keun Wook]; Steeghs, N[Steeghs, Neeltje]; Chao, Y[Chao, Yee]; Di Bartolomeo, M[Di Bartolomeo, Maria]; Garcia, MD[Garcia, Marc Diez]; Mohammad, NH[Mohammad, Nadia Haj]; Stein, A[Stein, Alexander]; McAdoo, W[McAdoo, William]; Winter, M[Winter, Megan]; Croydon, L[Croydon, Liz]; Lee, J[Lee, Jeeyun]
- Issue Date
- 1-Feb-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.4
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 4
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.